secwatch.observer — SEC 8-K summary
======================================

Issuer:     HERON THERAPEUTICS, INC. /DE/ (HRTX)
CIK:        0000818033
Form:       8-K
Filed at:   2025-10-15T23:59:59+00:00
Accession:  0001193125-25-240253
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Heron shareholders approve share issuances exceeding 19.99% threshold
---------------------------------------------------------------------

- On Oct 13, 2025, shareholders approved issuance of shares upon conversion of convertible notes due 2031 (89.6M for, 5.6M against).
- Shareholders also approved issuance upon automatic conversion of Series A Convertible Preferred Stock (91.5M for, 3.7M against).
- Both proposals passed to comply with Nasdaq Listing Rule 5635(d) for potential issuances exceeding 19.99% of outstanding common stock.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/818033/000119312525240253/0001193125-25-240253-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/818033/000119312525240253/hrtx-20251015.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-240253

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer